the Efficacy and Safety of Indobufen and Low-dose Aspirin in Different Regimens of Antiplatelet Therapy
Clinical trial NCT03230851 · UNKNOWN
Trial details
- NCT number
- NCT03230851
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-20
- Primary completion
- 2018-07-10
- Enrollment
- 210
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.